Status:

TERMINATED

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Lead Sponsor:

Maisonneuve-Rosemont Hospital

Collaborating Sponsors:

The Canadian Blood and Marrow Transplant Group

Conditions:

Respiratory Tract Infections

Bronchiolitis Obliterans

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

For many patients with blood cancers, stem cell transplantation from a family member or from an unrelated donor remains the only potentially curative option. Unfortunately, up to 40% of patients devel...

Eligibility Criteria

Inclusion

  • Allogeneic transplant within the prior 1 year
  • Age greater than or equal to 18 years
  • Capable of informed consent
  • Neutrophil engraftment has occurred
  • This is the first clinically-recognized episode of viral respiratory tract infection after transplant

Exclusion

  • Proof or high suspicion for bacterial, fungal or any non-viral microorganism causing pneumonia
  • CMV, VZV or HSV pneumonia
  • Prior diagnosis of a chronic transplant-related non-infectious pulmonary complication (ex: BO, COP)
  • Treating physician believes the risk of systemic steroids is too great
  • Currently receiving prednisone at or greater than 0.25 mg/kg/day or the equivalent dose of another steroid
  • Currently receiving pentostatin
  • Mycophenolate initiated de novo or increased within the past 4 weeks
  • Use of inhaled corticosteroids within the past 2 weeks for at least 1 week
  • Haploidentical or T-cell depleted graft
  • Lack of pre-transplant pulmonary function tests
  • Evidence of a prior symptomatic viral respiratory tract infection following transplant, whether treated or not
  • Allergy or adverse reaction to any of the study drugs
  • Relapse or progression of the underlying malignancy
  • Palliative care

Key Trial Info

Start Date :

September 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2013

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT01432080

Start Date

September 1 2011

End Date

December 30 2013

Last Update

October 20 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Maisonneuve-Rosemont Hospital (Hôpital Maisonneuve-Rosemont)

Montreal, Quebec, Canada, H1T 2M4